DCLL-9718S

DB17392InvestigationalProtein Based Therapies

DCLL9718S is an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1). DCLL9718S is under investigation in clinical trial NCT03298516 (A Study of DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid...

Mechanism: Pharmacologically active on C-type lectin domain family 12 member A
Curator reviewed
Also known as: DCLL9718S
Code names: RG-6109

Resolves to

Compound

UNIIYCH5V86R73

Targets

Q5QGZ9CLEC12A

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with DCLL-9718S, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account